학술논문

Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
Document Type
Article
Source
In: Journal of Nuclear Medicine. (Journal of Nuclear Medicine, 1 October 2021, 62(10):1447-1456)
Subject
Language
English
ISSN
2159662X
01615505